Pirfenidone Tablet, Coated
Product Images NDC 69097-987

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 69097-987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pirfenidone Figure1)

The text is a table showing the percentage of patients who experienced either a decrease or increase in %FVC (forced vital capacity) after taking Pirfenidone or a placebo over the course of 52 weeks. It is not available whether Pirfenidone or a placebo is more effective.*

FDA Label Image

Figure 2 (Pirfenidone Figure2)

The text describes the mean change in FVC (Forced Vital Capacity) in milliliters over a period of weeks after using Piferidone drug compared to Placebo. However, due to the lack of context and formatting issues, the information provided is difficult to interpret.*

FDA Label Image

Figure 3 (Pirfenidone Figure3)

This is a statistical table showing the percentage of patients alive in a clinical trial comparing the drug Pirferidone against a placebo. The table includes the number of patients in each group, hazard ratios, and confidence intervals. The survival rate of patients taking Pirferidone is higher than that of the placebo group.*

FDA Label Image

267 mg (Pirfenidone Pdp 1)

This is a description of a medication called Pirfenidone, which comes in tablet form. Each film-coated tablet contains 267mg of Pirfenidone. The medication is available via prescription only, with dosage information provided in the package insert. It is recommended to store between 15°C-30°C (59°F-86°F). The medication is manufactured by Cipla USA, Inc. and ScieGen Pharmaceuticals, Inc. respectively.*

FDA Label Image

267 mg (Pirfenidone Pdp 2)

This is a prescription medication called Pirfenidone that comes in the form of tablets. Each film-coated tablet contains 267 mg of Pirfenidone. The usual dosage should be found in the package insert. It should be stored at room temperature between 15° and 30°C (59° to 86°F). It will be harmful to children and must be kept out of their reach. Cipla USA, Inc. produces it and ScieGen Pharmaceuticals, Inc. manufactures it in Hauppauge, NY.*

FDA Label Image

801 mg (Pirfenidone Pdp 5)

This is a description of a medication with the NDC number 69097-98805. The medication is available only by prescription and each film-coated tablet contains 801 mg of pirfenidone. The usual dosage information can be found in the package insert. The tablets should be stored at 25°C (77°F), with excursions permitted up to 15° to 30°C (59° to 86°F) as per USP controlled room temperature guidelines. The manufacturer's address is ScieGen Pharmaceuticals, Inc. and the medication comes in a bottle of 90 tablets. The has also included an unintelligible number at the end, possibly as a result of a scanning error.*

FDA Label Image

801 mg (Pirfenidone Pdp 6)

This is a prescription medicine that comes in the form of a film-coated tablet. Each tablet contains 801 mg of pirfenidone, which is used to treat idiopathic pulmonary fibrosis. The usual dosage information can be found in the package insert. The medicine should be stored at a temperature between 25°C and 30°C. The tablets are manufactured by ScieGen Pharmaceuticals for Cipla USA Inc. and come in a bottle of 270 tablets. This medication should be kept out of reach of children. Full prescribing information is available for P I rfen I d 0 n e.*

FDA Label Image

Pirfenidone (Pirfenidone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.